Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
Ready to proceed? Start a request for Anaprazole on our secure patient portal to submit your prescription, upload documents and track your approval status.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
China
Regulatory Approval:
Your Trustworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Anaprazole is a proton pump inhibitor (PPI), a type of medicine that lowers the amount of acid the stomach makes. It was discovered and developed in China by Xuanzhu Biopharm, part of the Sihuan Pharmaceutical group, and is sold there as 安久卫® as enteric-coated 20 mg tablets.
China's National Medical Products Administration (NMPA) approved it on 21 June 2023 for one use:
The company has also applied in China for use in reflux oesophagitis, but that use is not approved yet. It is a prescription medicine, listed under our other therapeutic areas, and should be taken on a gastroenterologist's advice.
Like other PPIs, it switches off the proton pumps in the stomach lining that make acid, which gives an ulcer the chance to heal. What sets it apart is how the body clears it. It is broken down by several routes and only about 3.5% depends on the CYP2C19 enzyme, so a person's genes affect it less than older PPIs. It also leaves the body through both the gut and the kidneys, roughly 40% and 53%, rather than mostly through the kidneys.
In the phase 3 trial, 448 adults with an active duodenal ulcer took either anaprazole 20 mg or an established comparison PPI once a day for 4 weeks. The ulcer healed in about 93% of the anaprazole group (per-protocol analysis), which the trial judged no worse than the comparison medicine (96.6%). On the very first day, 81.2% of anaprazole patients said their acid reflux symptoms had gone, and healing was similar whatever their CYP2C19 gene type.
The label notes that the trials used a 4-week course, and there is no data yet on taking it for longer.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Liver enzymes: the trials reported raised liver enzymes. All cases were mild or moderate, but the label asks doctors to keep a close watch.
Side effects: 315 people with duodenal ulcer took it in the clinical trials. The common side effects (1–10%) were raised ALT (2.6%) and raised AST (1.5%) liver enzymes. Less often (under 1%), people had diarrhoea, stomach pain, hiccups, bloating, dry mouth, itching or sleepiness. Safety in pregnancy, breastfeeding and children has not been established in the published data.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
The tablets can be imported only in the patient's name, by the patient or a government hospital, in line with India's import regulations for unapproved medicines. You will need:
Once we have received and checked a valid prescription and, where needed, an import permit.
No. It is approved only in China. It has no CDSCO approval, it is not sold in Indian pharmacies, and the US FDA and European Medicines Agency have not approved it either.
Patients can still get it legally through the Named Patient Program (NPP), which allows a medicine not registered in India to be imported for one specific patient on a prescription.
It can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.
NamedPatientProgram.com (NPP) sources this medicine through the manufacturer's authorised supply channels in China and arranges supply to patients, doctors, and hospitals under applicable legal provisions. In China it is sold in packs of 6 tablets of 20 mg, so a 4-week course needs about 5 packs. The tablets travel in their sealed original packs under temperature-controlled shipping. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.
For the current cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.
Patients across India can access this medicine through regulated import pathways, with delivery arranged to the patient or the treating clinic on a valid prescription.
Patients in Delhi are close to our dispatch point in New Delhi, so a 4-week course can usually reach them quickly.
Gastroenterologists in Mumbai can request the medicine for a named patient once the endoscopy report is ready.
The tablets can be delivered to the patient's home or clinic in Bangalore after the documents are checked.
Patients across Tamil Nadu can use the same documented import route through Chennai.
We share a written quote first, so patients in Hyderabad know the full cost before ordering.
Deliveries to Kolkata and the eastern states are planned so treatment can start on the date the doctor has set.
Patients in Pune receive updates at each stage, from order to delivery.
The treating doctor in Ahmedabad can send us the prescription to start the import in the patient's name.
Serves patients from Punjab, Haryana and Himachal Pradesh, with delivery to the patient or the clinic.
Patients in Rajasthan can receive the medicine without travelling, as long as the import is in their name.
We coordinate delivery for patients treated at public and private hospitals in Uttar Pradesh.
Patients across Kerala can have the course delivered to their home or clinic in Kochi.
Access can also be coordinated for patients in other Indian cities, subject to a valid prescription and regulatory requirements.
Written By
Nitin GoswamiDeputy Manager – Content & Social Media, Ikris Pharma Network
Sources: NMPA • CDSCO
Last Updated: 16 October 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
